HEMATOLOGIC MALIGNANCY
Clinical trials for HEMATOLOGIC MALIGNANCY explained in plain language.
Never miss a new study
Get alerted when new HEMATOLOGIC MALIGNANCY trials appear
Sign up with your email to follow new studies for HEMATOLOGIC MALIGNANCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug tested for Tough-to-Treat blood cancers
Disease control TerminatedThis early-stage study tested a new drug called BR108 injection in adults with advanced blood cancers that had returned or stopped responding to other treatments. The main goal was to check the safety, side effects, and how the body processes the drug. The study was terminated af…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE1 • Sponsor: BioRay Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Radiation boost after CAR-T: a new shot at fighting stubborn lymphoma
Disease control TerminatedThis small, early-stage study tested whether adding a short course of radiation therapy could help control lymphoma that did not fully respond to CAR-T cell therapy. The goal was to see if radiation could improve the body's immune response against the cancer and work together wit…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New antibiotic strategy tested for dangerous infections in vulnerable cancer patients
Disease control TerminatedThis study tested whether a specific antibiotic (ceftolozane-tazobactam) works better than standard antibiotics to treat serious Pseudomonas infections in people with blood cancers or who have had a stem cell transplant. Participants received the antibiotic through an IV, and res…
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC
-
Study halted early: new approach tested to shield kids from transplant complications
Disease control TerminatedThis study tested a new plan for medications given after a bone marrow transplant to prevent a serious complication called graft-versus-host disease (GVHD). It involved children and young adults with blood cancers who received a transplant from a matched donor. The main goal was …
Matched conditions: HEMATOLOGIC MALIGNANCY
Phase: PHASE2 • Sponsor: St. Jude Children's Research Hospital • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC